HD
EMA's human medicines committee (CHMP) has started the first 'rolling review' of the COVID-19 vaccine developed by AstraZeneca and Oxford University, the first step in the approval process. The EMA said it’s starting the review based on preliminary results and that it doesn't mean "that a conclusion can be reached yet on the vaccine’s safety and effectiveness."
EMA's human medicines committee (CHMP) has started the first 'rolling review' of the COVID-19 vaccine developed by AstraZeneca and Oxford University, the first step in the approval process. The EMA said it’s starting the review based on preliminary results and that it doesn't mean "that a conclusion can be reached yet on the vaccine’s safety and effectiveness."
Contact your sales representative for commercial and promotional uses.